Inactive Instrument
Lipidor AB Stock Nasdaq Stockholm
Stocks
LIPI
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -6.52% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.52% | -24.56% | - | - | 92.63K | |
| +1.15% | +1.35% | +48.36% | +160.16% | 1,057B | |
| +1.33% | +4.13% | +55.40% | +54.02% | 624B | |
| -0.39% | +1.89% | +35.88% | +81.10% | 454B | |
| +1.60% | +7.09% | +35.90% | +29.32% | 341B | |
| -0.60% | +2.95% | +36.28% | +39.04% | 297B | |
| -0.14% | +0.60% | +16.17% | +17.53% | 262B | |
| +0.09% | -2.82% | -28.29% | -41.71% | 215B | |
| -0.54% | +2.87% | +22.12% | +60.06% | 201B | |
| -1.23% | -3.17% | +14.87% | +67.43% | 162B | |
| Average | -0.26% | +0.77% | +26.30% | +51.88% | 401.55B | |
| Weighted average by Cap. | +0.69% | +1.57% | +35.98% | +77.50% |
Employees
4
Sector
Pharmaceuticals
